Dry AMD Symposium 1

Related

• 

  Results From Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity

  Rishi P. Singh, MD

  Annual Meeting Talks

  2024

• 

  Surveying the Dry AMD Landscape. Is help on the way?

  David S. Boyer, MD

  Updates from the Field

  2019

• 

  Prospective Longitudinal Study: Fluid Quantification From Daily Self-imaging With Home OCT in Neovascular Age-Related Macular Degeneration

  Jeffrey S. Heier, MD

  Annual Meeting Talks

  2021